abecarnil

Known as: isopropyl 6-benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylate 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Treatment with diazepam (25 mg/kg; p.o., twice-daily for 17 days) induced tolerance to the anticonvulsant effect of diazepam… (More)
Is this relevant?
1997
1997
Abrupt termination of the treatment of humans with benzodiazepines (BDZs) leads to a rapid onset of discontinuation syndrome… (More)
Is this relevant?
1997
1997
In a placebo-controlled, multicenter study, 180 male and female outpatients, ages 18-65, with DSM-III-R generalized anxiety… (More)
Is this relevant?
1996
1996
Diazepam and abecarnil produce their overt effects by interaction with the GABAA receptor. Chronic treatment with abecarnil… (More)
Is this relevant?
1996
1996
Acute foot shock stress elicits a selective and time-dependent increase of neuroactive steroid (pregnenolone, progesterone… (More)
Is this relevant?
1996
1996
The effects of acutely administered diazepam and the beta-carboline abecarnil were examined in two animal models of anxiety in… (More)
Is this relevant?
1995
1995
Abecarnil, a novel beta-carboline, is under development for the treatment of Generalized Anxiety Disorder. This study compared… (More)
Is this relevant?
1993
1993
Abecarnil (isopropyl-6-benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylate) is a metabolically stable anxiolytic and… (More)
Is this relevant?
1992
1992
Abecarnil, a beta-carboline acting at benzodiazepine receptors, has been shown to have anxiolytic and anticonvulsant properties… (More)
Is this relevant?
1990
1990
Abecarnil (isopropyl 6-benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylate) is a novel ligand for central benzodiazepine (BZ… (More)
Is this relevant?